Viraclean® passes TGA Option B and kills a broad range of other bacteria including Coronaviruses SARS-CoV-2 (COVID-19), Enterococcus Faecalis (VRE), Acetobacter and Acinetobacter and is also proven effective against Hepatitis B Virus, Herpes Simplex Virus and the Influenza Virus.
Viraclean® is a major development in advanced cleaning and disinfecting technology from Whiteley Medical. It is the result of years of intensive research and development. A considerable investment in both time and money has been made in the interests of improving the safety and efficacy of hospital grade disinfectants.
The revolutionary hepadnacidal test method was developed at the University of Sydney sponsored with funding from Whiteley Medical and represents another world breakthrough in Australia. This glutaraldehyde-free product, Viraclean®, which was developed during this program, has been patented.